prostatitis
PROSTATITIS

Prostatitis is the inflammation of the prostate that may be caused by infection, chronic pelvic pain syndrome or asymptomatic prostate inflammation.

Prominent features are genitourinary, pelvic or rectal pain and lower urinary tract symptoms, eg urinary frequency, urgency, hesitancy, weak stream and straining on urination, dysuria, pain that increased with urination.

Prostatitis Management

Follow Up

  • Persistent prostatitis may be managed by another course of antibiotic therapy adjusted according to susceptibility results; course is more prolonged & consists of a higher dosage or different agent
  • Consider referral to a specialist for evaluation if patient is unresponsive to modified antibiotic therapy or if w/ severe symptoms
Acute Bacterial Prostatitis (ABP)
  • Assess clinical response on follow-up along with a urine culture collected 7 days after antibiotic therapy
  • Suspect a prostatic abscess if patient failed to improve with antibiotic therapy
  • Complications of acute bacterial prostatitis (ABP) include acute urinary retention, prostatic abscess, chronic bacterial prostatitis, fistula formation, sepsis, or spread of infection to spine or sacroiliac joints
Chronic Bacterial Prostatitis & Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CBP & CP/CPPS)
  • May use the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) & InternationalProstate Symptom Score (IPSS) as validated tools for determining improvement of patient’s symptoms or quality of life w/ time or treatment
    • A 6-point decrease from baseline in the total score of National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) is the threshold for prediction of response to treatment
  • Patients refractory to treatment may be given the following:
    • Psychosocial screening, eg history of trauma including emotional, physical, or sexual abuse, for possible referral to mental health services
    • Consider giving phytotherapy, eg bioflavonoids, pollen extracts, &/or saw palmetto, as a treatment option
Editor's Recommendations
Most Read Articles
6 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 6 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
20 Sep 2020
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.